Achieve Life Sciences
Yahoo Finance • 18 days ago
Achieve Life Sciences GAAP EPS of -$0.80 misses by $0.64
* Achieve Life Sciences press release [https://seekingalpha.com/pr/20614674-achieve-life-sciences-reports-second-quarter-2026-financial-results-and-provides-business] (ACHV [https://seekingalpha.com/symbol/ACHV]): Q2 GAAP EPS of -$0.80 m... Full story
Yahoo Finance • 2 months ago
Achieve Life Sciences Joins Russell 2000® Index
SEATTLE and VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercia... Full story
Yahoo Finance • 2 months ago
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficiencies Identified SEATTLE and VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the... Full story
Yahoo Finance • 4 months ago
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * JD.com (JD [https://seekingalpha.com/symbol/JD]) * Sea Limited (SE [https://seekingalpha.com/symbol/SE]) * D-Wave Quantum (QBTS [https://seekingalpha.com/symbol/QBTS])... Full story
Yahoo Finance • 9 months ago
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
SEATTLE and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story
Yahoo Finance • 9 months ago
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation
Achieve Life Sciences Inc. (NASDAQ:ACHV) is one of the Canadian penny stocks to buy right now. Lake Street’s Thomas Flaten maintained a Buy rating on Achieve Life Sciences Inc. (NASDAQ:ACHV) at $11.00 on November 7.FDA Accepts Achieve Life... Full story
Yahoo Finance • 10 months ago
Achieve Life Sciences outlines expedited FDA review for cytisinicline and targets Q3/Q4 2026 launch
Earnings Call Insights: Achieve Life Sciences (ACHV) Q3 2025 MANAGEMENT VIEW * CEO Richard A. Stewart described the quarter as "another truly significant quarter for Achieve in our mission to get a new treatment for nicotine dependence... Full story
Yahoo Finance • 10 months ago
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner’s National Priority Voucher for E-cigarette or Vaping Cessation Conference Call Scheduled for 8:30 AM EST Today, November 6, 2025 SEATTLE and VANCOUVER, British Colum... Full story
Yahoo Finance • 10 months ago
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully Concluded DSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns SEATTLE and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEW... Full story
Yahoo Finance • 10 months ago
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story
Yahoo Finance • 10 months ago
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
SEATTLE and VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story
Yahoo Finance • 10 months ago
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway One of Only Nine Therapies Chosen for the FDA’s Inaugural National Priority Voucher Program SEATTLE and VANCO... Full story
Yahoo Finance • 10 months ago
Achieve, Disc, Revolution among winners of initial FDA national priority vouchers
[US Food and Drug Administration (FDA)] Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]), Disc Medicine (NASDAQ:IRON [https://seekingalpha.com/symbol/IRON]), and Revolution Medicines (NASDAQ:RVMD [https://seeking... Full story
Yahoo Finance • 11 months ago
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
SEATTLE and VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story
Yahoo Finance • 11 months ago
Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD
SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story
Yahoo Finance • 11 months ago
Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer
SEATTLE and VANCOUVER, British Columbia, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story
- CMC
Mentioned:
Yahoo Finance • 12 months ago
Achieve Life Sciences gets new interim chief medical officer
* Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]) said that [https://seekingalpha.com/pr/20230175-achieve-life-sciences-names-dr-mark-rubinstein-interim-chief-medical-officer] Mark Rubinstein, M.D., will assume... Full story
Yahoo Finance • 12 months ago
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story
Yahoo Finance • 12 months ago
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
SEATTLE and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story
Yahoo Finance • last year
Which stocks are moving before the opening bell on Monday?
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT O... Full story